Cargando…
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study
BACKGROUND: Clinical outcome of adrenocortical carcinoma (ACC) varies because of its heterogeneous nature and reliable prognostic prediction model for adult ACC patients is limited. The objective of this study was to develop and externally validate a nomogram for overall survival (OS) prediction in...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882048/ https://www.ncbi.nlm.nih.gov/pubmed/31775884 http://dx.doi.org/10.1186/s40880-019-0426-0 |
_version_ | 1783474070578266112 |
---|---|
author | Kong, Jianqiu Zheng, Junjiong Cai, Jinhua Wu, Shaoxu Diao, Xiayao Xie, Weibin Chen, Xiong Liao, Chenyi Yu, Hao Fan, Xinxiang Huang, Chaowen Liu, Zhuowei Chen, Wei Lv, Qiang Qin, Haide Huang, Jian Lin, Tianxin |
author_facet | Kong, Jianqiu Zheng, Junjiong Cai, Jinhua Wu, Shaoxu Diao, Xiayao Xie, Weibin Chen, Xiong Liao, Chenyi Yu, Hao Fan, Xinxiang Huang, Chaowen Liu, Zhuowei Chen, Wei Lv, Qiang Qin, Haide Huang, Jian Lin, Tianxin |
author_sort | Kong, Jianqiu |
collection | PubMed |
description | BACKGROUND: Clinical outcome of adrenocortical carcinoma (ACC) varies because of its heterogeneous nature and reliable prognostic prediction model for adult ACC patients is limited. The objective of this study was to develop and externally validate a nomogram for overall survival (OS) prediction in adult patients with ACC after surgery. METHODS: Based on the data from the Surveillance Epidemiology, and End Results (SEER) database, adults patients diagnosed with ACC between January 1988 and December 2015 were identified and classified into a training set, comprised of 404 patients diagnosed between January 2007 and December 2015, and an internal validation set, comprised of 318 patients diagnosed between January 1988 and December 2006. The endpoint of this study was OS. The nomogram was developed using a multivariate Cox proportional hazards regression algorithm in the training set and its performance was evaluated in terms of its discriminative ability, calibration, and clinical usefulness. The nomogram was then validated using the internal SEER validation, also externally validated using the Cancer Genome Atlas set (TCGA, 82 patients diagnosed between 1998 and 2012) and a Chinese multicenter cohort dataset (82 patients diagnosed between December 2002 and May 2018), respectively. RESULTS: Age at diagnosis, T stage, N stage, and M stage were identified as independent predictors for OS. A nomogram incorporating these four predictors was constructed using the training set and demonstrated good calibration and discrimination (C-index 95% confidence interval [CI], 0.715 [0.679–0.751]), which was validated in the internal validation set (C-index [95% CI], 0.672 [0.637–0.707]), the TCGA set (C-index [95% CI], 0.810 [0.732–0.888]) and the Chinese multicenter set (C-index [95% CI], 0.726 [0.633–0.819]), respectively. Encouragingly, the nomogram was able to successfully distinguished patients with a high-risk of mortality in all enrolled patients and in the subgroup analyses. Decision curve analysis indicated that the nomogram was clinically useful and applicable. CONCLUSIONS: The study presents a nomogram that incorporates clinicopathological predictors, which can accurately predict the OS of adult ACC patients after surgery. This model and the corresponding risk classification system have the potential to guide therapy decisions after surgery. |
format | Online Article Text |
id | pubmed-6882048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68820482019-12-03 A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study Kong, Jianqiu Zheng, Junjiong Cai, Jinhua Wu, Shaoxu Diao, Xiayao Xie, Weibin Chen, Xiong Liao, Chenyi Yu, Hao Fan, Xinxiang Huang, Chaowen Liu, Zhuowei Chen, Wei Lv, Qiang Qin, Haide Huang, Jian Lin, Tianxin Cancer Commun (Lond) Original Article BACKGROUND: Clinical outcome of adrenocortical carcinoma (ACC) varies because of its heterogeneous nature and reliable prognostic prediction model for adult ACC patients is limited. The objective of this study was to develop and externally validate a nomogram for overall survival (OS) prediction in adult patients with ACC after surgery. METHODS: Based on the data from the Surveillance Epidemiology, and End Results (SEER) database, adults patients diagnosed with ACC between January 1988 and December 2015 were identified and classified into a training set, comprised of 404 patients diagnosed between January 2007 and December 2015, and an internal validation set, comprised of 318 patients diagnosed between January 1988 and December 2006. The endpoint of this study was OS. The nomogram was developed using a multivariate Cox proportional hazards regression algorithm in the training set and its performance was evaluated in terms of its discriminative ability, calibration, and clinical usefulness. The nomogram was then validated using the internal SEER validation, also externally validated using the Cancer Genome Atlas set (TCGA, 82 patients diagnosed between 1998 and 2012) and a Chinese multicenter cohort dataset (82 patients diagnosed between December 2002 and May 2018), respectively. RESULTS: Age at diagnosis, T stage, N stage, and M stage were identified as independent predictors for OS. A nomogram incorporating these four predictors was constructed using the training set and demonstrated good calibration and discrimination (C-index 95% confidence interval [CI], 0.715 [0.679–0.751]), which was validated in the internal validation set (C-index [95% CI], 0.672 [0.637–0.707]), the TCGA set (C-index [95% CI], 0.810 [0.732–0.888]) and the Chinese multicenter set (C-index [95% CI], 0.726 [0.633–0.819]), respectively. Encouragingly, the nomogram was able to successfully distinguished patients with a high-risk of mortality in all enrolled patients and in the subgroup analyses. Decision curve analysis indicated that the nomogram was clinically useful and applicable. CONCLUSIONS: The study presents a nomogram that incorporates clinicopathological predictors, which can accurately predict the OS of adult ACC patients after surgery. This model and the corresponding risk classification system have the potential to guide therapy decisions after surgery. BioMed Central 2019-11-27 /pmc/articles/PMC6882048/ /pubmed/31775884 http://dx.doi.org/10.1186/s40880-019-0426-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Article Kong, Jianqiu Zheng, Junjiong Cai, Jinhua Wu, Shaoxu Diao, Xiayao Xie, Weibin Chen, Xiong Liao, Chenyi Yu, Hao Fan, Xinxiang Huang, Chaowen Liu, Zhuowei Chen, Wei Lv, Qiang Qin, Haide Huang, Jian Lin, Tianxin A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
title | A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
title_full | A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
title_fullStr | A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
title_full_unstemmed | A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
title_short | A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
title_sort | nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882048/ https://www.ncbi.nlm.nih.gov/pubmed/31775884 http://dx.doi.org/10.1186/s40880-019-0426-0 |
work_keys_str_mv | AT kongjianqiu anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT zhengjunjiong anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT caijinhua anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT wushaoxu anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT diaoxiayao anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT xieweibin anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT chenxiong anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT liaochenyi anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT yuhao anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT fanxinxiang anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT huangchaowen anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT liuzhuowei anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT chenwei anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT lvqiang anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT qinhaide anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT huangjian anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT lintianxin anomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT kongjianqiu nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT zhengjunjiong nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT caijinhua nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT wushaoxu nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT diaoxiayao nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT xieweibin nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT chenxiong nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT liaochenyi nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT yuhao nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT fanxinxiang nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT huangchaowen nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT liuzhuowei nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT chenwei nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT lvqiang nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT qinhaide nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT huangjian nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy AT lintianxin nomogramforindividualizedestimationofsurvivalamongadultpatientswithadrenocorticalcarcinomaaftersurgeryaretrospectiveanalysisandmulticentervalidationstudy |